🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It has been my honor to do my PhD training alongside such a great Scientist and mentor as you, Britta Britta Will!

Leaders who refuse to hear criticism choose not to learn. The higher you climb, the more people hesitate to challenge you. Silencing dissent is a step toward becoming a dictator. A culture of voice begins with admitting gaps in your knowledge and rewarding those who speak up.

Toxic positivity is pressuring people to look on the bright side. They have to suppress anxiety, anger, sadness, and grief. Healthy support is shielding people from the dark side. You invite them to express their pain, and show them they're not alone and won't feel it forever.

Albert Einstein College of Medicine - Official Such a treat to be there today to cheer on Maria Aivalioti, Taneisha Sinclair, M.D., Justin Wheat, Josh Weinreb, Richard Piszczatowski MD, PhD, Meng Maxine Tong, and Yu Liu! Congratulations to all the graduates!

The older I get the more I realize the importance of walking away from people and situations that threaten my peace of mind, values, self-worth and self-respect..

Learning to be calm when you are disrespected is a superpower

We are looking for a Scientist (PhD level) Regeneron with expertise in CRISPR-based technologies to translate discoveries from multi-omics profiling of preclinical cancer models and patient samples into novel therapeutics. Spread the word! regeneron.wd1.myworkdayjobs.com/Careers/job/TA…

news.sky.com/story/nasa-rev…

PU.1-dependent enhancer inhibition separates Tet2-deficient #hematopoiesis from malignant transformation, by Maria Aivalioti et al. bit.ly/3yFU5qn Albert Einstein College of Medicine - Official

Thanks Blood Cancer Discovery - it was such a smooth and enjoyable time working with you! Thank you Britta Will, our team, Eleni Zint, our collaborators Amit Verma Aaron Viny Ross Levine, Amittha Wickrema for their immense support in progressing our work!

At #ESMO2022, we are sharing first-in-human data in two novel investigational bispecific antibodies in advanced solid tumors.

#BREAKING: We announced positive Phase 2 investigational data in neoadjuvant #CSCC, presented today at #ESMO22 and published in NEJM. Learn more at the link below.

Thank you Eric Pietras, Wolfgang Schleicher and Blood Cancer Discovery for the amazing and thoughtful commentary on our work!!

We are proud to announce our #Ebola medicine, the first FDA-approved recombinant monoclonal antibody for this devastating disease, was recognized as the #PrixGalien "Best Biotechnology Product of 2022" by the The Galien Foundation.

#BREAKING: The U.S. FDA has approved our immunotherapy for use in combination with chemotherapy as first-line treatment in certain types of advanced #NSCLC.

Congratulations Britta Will Britta, Christine and Jiahao on this phemomenal work!! Very proud of my old colleagues and PhD lab!